ONCSQ — OncoSec Medical Incorporated Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
OncoSec Medical: Down on discounted stock offering
Brief: Oncosec Medical Incorporated Announces Pricing Of Public Offering
Brief: OncoSec Medical Inc Announces Proposed Public Offering Of Common Stock
Brief: OncoSec Appoints Kellie Malloy Foerter As Chief Operating Officer
Brief: OncoSec Set To Join Russel Microcap Index
Brief: OncoSec Expands Keynote-890 Trial Into First-Line Metastatic Triple Negative Breast Cancer With Tavo And Keytruda Plus Chemotherapy
Brief: Oncosec Strengthens Ip Portfolio With Three New Patents Covering Tavo™ And Its Electroporation Gene Delivery System
Brief: Oncosec Presents Pre-Clinical Data From Visceral Lesion Applicator & Apollo Feasibility Study
Brief: OncoSec Appoints Oncologist And Immunologist Herbert Kim Lyerly To Board Of Directors
Brief: Oncosec Collaborates With Providence Cancer Institute To Conduct First-In-Human Trial Of Oncosec's Corvax12
Brief: OncoSec Announces Publication Of Positive Tavo Monotherapy Results In Metastatic Melanoma Patients In Annals Of Oncology
Brief: OncoSec Announces That The Class Action And Related Litigation Brought By Alpha Holdings Have Been Dismissed By Nevada State Court With Prejudice
Brief: Oncosec Strengthens Its Board Of Directors With Three New Appointments
Brief: OncoSec Announces Closing Of The CGP/Sirtex Transaction
Brief: Oncosec Announces That Nevada Court Denies Alpha Holdings’ Motion To Enjoin Special Meeting Of Shareholders
Brief: Oncosec Medical Issues Statement To Shareholders Regarding Alpha Holdings' Renewed Offer
Brief: Data From Oncosec's Visceral Lesion Applicator (Vla) To Be Presented At The Society Of Interventional Oncology Annual Meeting
Brief: OncoSec Appoints Robert J. Delaversano As Principal Accounting Officer And Controller
Brief: OncoSec Medical Inc - Urges Shareholders To Vote For CGP/Sirtex Transaction On White Proxy Card Today